Skip to main content

Table 3 Results from meta-analysis, FEV1/FVC and AAT, adult cohorts

From: SERPINA1 methylation and lung function in tobacco-smoke exposed European children and adults: a meta-analysis of ALEC population-based cohorts

CpG

Position

Gene Group

SAPALDIA

Meta- Analysis of Lung Function Association in SAPALDIA, NFBC and ECRHS

Circulating AAT

Cross-Sectional T1

Cross-Sectional T2

Repeat Cross-Sectional

Change

Coef.

P.valuea

Coef.

P.valuea

Directionb

Coef.

P.valuea

Directionb

Coef.

P.valuea

Directionb

Coef.

P.valuea

Directionb

cg10761141

94,844,776

3UTR

−0.30

0.25

0.10

0.14

−++

−0.02

0.79

+ − +

−0.01

0.79

– − +

0.00

0.82

+ − –

cg25042671

94,849,061

Body

−0.59

0.04

−0.09

0.29

− + −

− 0.12

0.22

– – –

−0.12

0.03

+ − –

0.00

0.62

+ − +

cg20267408

94,849,703

5UTR

−0.44

0.21

−0.05

0.57

– – –

0.05

0.59

−++

0.01

0.88

+ − +

0.00

0.78

−++

cg26938334

94,849,747

5UTR

1.16

0.42

0.10

0.24

− + −

−0.10

0.47

−++

0.01

0.84

++−

−0.01

0.33

– − +

cg10832639

94,850,965

5UTR

−0.25

0.72

0.16

0.14

+ − +

0.02

0.86

− + −

0.08

0.18

+++

0.01

0.32

+++

cg02126235

94,855,034

5UTR

−0.30

0.58

0.26

0.06

+++

0.06

0.71

− + −

0.06

0.41

++−

0.00

0.90

– − +

cg09968361

94,855,344

5UTR

−0.33

0.44

0.11

0.23

+++

0.00

0.99

++−

0.05

0.25

++−

−0.01

0.37

– − +

cg13826459

94,855,505

TSS1500

−0.08

0.76

0.07

0.34

+ − +

0.15

0.05

+ − +

0.04

0.32

+++

0.01

0.24

−++

cg25968219

94,855,590

TSS1500

−1.81

0.05

0.31

0.02

+++

−0.16

0.43

– − +

− 0.01

0.90

−++

0.00

0.59

+ − +

cg01606800

94,855,990

TSS1500

−1.08

0.001

0.17

0.05

+ − +

0.01

0.96

– − +

0.00

0.97

– − +

0.00

0.73

++−

cg02181506

94,856,984

1stExon

−0.78

0.08

−0.01

0.89

+ − –

0.05

0.64

+ − –

−0.03

0.58

+ − –

0.00

0.80

++−

cg10070185

94,857,151

TSS200

−0.05

0.91

0.07

0.45

+++

0.19

0.09

−++

−0.01

0.81

– − +

0.00

0.63

– − +

cg24621042

94,857,275

TSS1500

−0.68

0.04

0.18

0.02

+++

0.16

0.08

+++

0.07

0.09

+++

−0.01

0.09

+ − –

cg00802237

94,858,066

TSS1500

−0.07

0.81

0.03

0.71

+ − +

−0.14

0.09

– – –

0.00

0.96

−++

0.00

0.50

+ − –

cg04179148

94,858,339

TSS1500

−0.70

0.06

0.20

0.03

+++

0.04

0.73

++−

0.12

0.02

+++

0.00

0.57

– – –

  1. Cross-Sectional and repeat cross-sectional models adjusted for: study center, age, age2, education, height, height2, sex, sex*age, (sex*age) 2, sex*height, (sex*height)2, Bcell, CD4T, CD8T, Eos, Mono, NK. Repeat cross-sectional in addition ran with a random intercept on the subject. In predictive models, annual change in lung function was computed as the difference between T2 and T1 divided by time of follow-up: (T2-T1)/follow-up, models adjusted for covariates from T1
  2. Sample size for circulating AAT for SAPALDIA n = 561. Cross-sectional and prediction models (change) n = 1076, and n = 1122 for repeat cross-sectional models
  3. Results from Meta-Analysis of Lung Function Association of Methylation of CpGs in the SERPINA1* Gene with FEV1/FVC Level and Decline in Adult Ever-Smokers from SAPALDIA, ECRHS and NFBC and with Circulating AAT Concentrations in SAPALDIA
  4. From SERPINA gene cluster located on chromosome 14 between positions: 94′’641’781 and 95′’235’125 (human genome build 37/hg19)
  5. aNominal P-values, Bonferroni corrected significance level for 119 tests is P-value 4.6 × x10-4
  6. bDirection of effect for SAPALDIA, ECRHS and NFBC. A positive sign indicates that an increase in methylation is associated with higher level of lung function (cross-sectional models) and with an attenuation of lung function decline, respectively (change model)
  7. Statistically significant results are highlighted in bold